Who is SenzaGen (SENZA:ST) SenzaGen AB is developing in vitro tests for classification of skin and respiratory sensitizers and their potency. SenzaGen has developed a technology platform called GARD (Genomic Allergen Rapid Detection). The GARD technology platform was developed in Lund University with support by the EU program Sens-it-iv during 2005-2010, under supervision by Prof….